Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Foreign antigen delivered to CLL B cells via membrane IgD leads to a distinct antigen processing pathway that allows antigen-specific T cell activation that is superior to membrane IgM delivery

Martina Cardillo, Matthew Friedman, Xiao Yan, Anita Kar Yun Ng, Randall Davis, Michael Ryan, Peter Gregersen, Steven Allen, Jonathan Kolitz, Kanti Rai, Paolo Ghia, Nicholas Chiorazzi

Blood (2025) 146 (Supplement 1): 3882.

https://doi.org/10.1182/blood-2025-3882

Published: 2025

Journal Articles

Systematic molecular profiling to identify determinants of response to ibrutinib

Blood (2025) 146 (Supplement 1): 3881.

https://doi.org/10.1182/blood-2025-3881

Published: 2025

Journal Articles

Predictors of 90-day mortality in elderly and unfit AML patients treated with single-agent hypomethylating agents or in combination with venetoclax

Melissa F. Neumann, Meredith Akerman, David Mueller, Nicholas Scelzi, Jasmine Cho, Aaron Goldstein, Shreya Sanghani, Stephanie Boisclair, Erin Jou, Bradley Goldberg, Jonathan Kolitz, Douglas Gladstone, Kanti Rai, David W. Chitty

Blood (2025) 146 (Supplement 1): 5166.

https://doi.org/10.1182/blood-2025-5166

Published: 2025

Journal Articles

Normal B Cells in MBL follow divergent maturation pathways that correlate with the IGHV mutation status of the pre-leukemic clone

Gonzalo Blanco, Xiao Yan, Anita Kar Yun Ng, Andrew Shih, Jacqueline Aldridge, Anna Puiggros, Lindybeth Sarmiento, Jonathan Kolitz, Steven Allen, Kanti Rai, Douglas Stewart, Blanca Espinet, Gerald Marti, Neil Caporaso, Marcelo Navarrete, Nicholas Chiorazzi

Blood (2025) 146 (Supplement 1): 3910.

https://doi.org/10.1182/blood-2025-3910

Published: 2025

Journal Articles

CLL Stereotyped Subset #4 Igs Acquire Binding to Viable B Lymphocyte Surfaces By Somatic Mutations, Isotype Class Switching, and with the Prerequisite of IG Self-Association

Yun Liu, MS, Rosa Catera, PhD, Chao Gao, PhD, Xiao J. Yan, MDPhD, Steven L. Allen, MD, Jonathan E. Kolitz, MD, Kanti Rai, MD, Charles C Chu, PhD, Ten Feizi, MD, Kostas Stamatopoulos, Nicholas Chiorazzi, MD

Blood (2017) 130 (Supplement 1): 58.

https://doi.org/10.1182/blood.V130.Suppl_1.58.58

Published: 2017

Journal Articles

Ibrutinib Disrupts IL-4R - IL-4 Axis By Inhibiting IL-4R Signaling and Reversing Th2/Th1 Polarization through Diminished CLECL1 in CLL B Cells

Shih-Shih Chen, PhD, Priyadarshini Ravichandran, Gerardo Ferrer, PhD, Andrea Nicola Mazzarello, PhD, Florencia Palacios, PhD, Michael Ibrahim, Yasmine Kieso, Jacqueline C. Barrientos, MD, Edward Clark, PhD, Barbara Sherry, PhD, Jan A. Burger, MD PhD, Kanti Rai, MD, Nicholas Chiorazzi, MD

Blood (2017) 130 (Supplement 1): 387.

https://doi.org/10.1182/blood.V130.Suppl_1.387.387

Published: 2017

Journal Articles

IgM and IgD Differential CLL BCRs Organization and Interaction with Co-Receptors before and during Ibrutinib Therapy

Andrea Nicola Mazzarello, PhD, Marcus Dühren-von Minden, PhD, Palash Chandra Maity, PhD, Gentner Eva, PhD, Stefano Vergani, PhD, Gerardo Ferrer, PhD, Davide Bagnara, PhD, Shih-Shih Chen, PhD, Sophia Yancopoulos, Xiao J. Yan, MDPhD, Jacqueline C. Barrientos, MD, Kanti Rai, MD, Hassan Jumaa, PhD, Nicholas Chiorazzi, MD

Blood (2017) 130 (Supplement 1): 1716.

https://doi.org/10.1182/blood.V130.Suppl_1.1716.1716

Published: 2017

Journal Articles

Reactive Oxygen Species and Metabolic Gene Expression Profiling Further Differentiate CXCR4/CD5 Fractions in Chronic Lymphocytic Leukemia

Eric Sturgill, BA, Xiao J. Yan, MDPhD, Florencia Palacios, PhD, Kanti Rai, MD, Jacqueline C. Barrientos, MD, Steven L. Allen, MD, Jonathan E. Kolitz, MD, Nicholas Chiorazzi, MD

Blood (2017) 130 (Supplement 1): 4287.

https://doi.org/10.1182/blood.V130.Suppl_1.4287.4287

Published: 2017

Journal Articles

Myeloid-Derived Suppressor Cell Subtypes Are Responsible for the Th2 Phenotype of T Cells in CLL

Gerardo Ferrer, PhD, Brendan Franca, BS, Pui Yan Chiu, Stefano Vergani, PhD, Andrea Nicola Mazzarello, PhD, Florenca Palacios, PhD, Shihshih Chen, PhD, Davide Bagnara, PhD, Sophia Yancopoulos, Yun Liu, MS, Aliki Xochelli, MD, Xiao J. Yan, MDPhD, Jonathan E. Kolitz, MD, Steven L. Allen, MD, Jacqueline C. Barrientos, MD, Kostas Stamatopoulos, Kanti Rai, MD, Barbara Sherry, PhD, Nicholas Chiorazzi, MD

Blood (2017) 130 (Supplement 1): 4294.

https://doi.org/10.1182/blood.V130.Suppl_1.4294.4294

Published: 2017

Journal Articles

B Cells of the Proliferative Fraction of CLL Clones Exhibit Activated B-Cell and Myeloid-Cell Signatures Suggesting Enhanced Antigen-Presentation, Integrin Responsiveness, and IL-4 Receptiveness: Additional Targets for CLL Therapy

Xiao-Jie Yan, MD PhD, Florencia Palacios, PhD, Wentian Li, PhD, Sophia Yancopoulos, PhD, Carlo Calissano, MD, Jacqueline C. Barrientos, MD, Steven L. Allen, MD, Jonathan E. Kolitz, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD

Blood (2016) 128 (22): 302.

https://doi.org/10.1182/blood.V128.22.302.302

Published: 2016

Journal Articles

Fcgammariib Expression As a Prognostic Marker in Chronic Lymphocytic Leukemia

Rosa Bosch, Gerardo Ferrer, Eva Puy Vicente, Alba Mora, Rajendra N. Damle, Sergey Gorlatov, Kanti Rai, Emili Montserrat, Jorge Sierra, Nicholas Chiorazzi, Carol Moreno

Blood (2015) 126 (23): 1727.

https://doi.org/10.1182/blood.V126.23.1727.1727

Published: 2015

Journal Articles

The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia

Jennifer R. Brown, Jacqueline C. Barrientos, Paul M. Barr, Ian W. Flinn, Jan A. Burger, Anh Tran, Fong Clow, Danelle F. James, Thorsten Graef, Jonathan W. Friedberg, Kanti Rai, Susan O’Brien

Blood (2015) 125 (19): 2915–2922.

https://doi.org/10.1182/blood-2014-09-585869

Published: 2015

Includes: Supplemental data

Journal Articles

Efficiency of BCR: Anti-BCR Interaction Dictates Cellular Outcomes of Signaling in Chronic Lymphocytic Leukemia Cells

Rajendra Damle, Sonal Temburni, Tara Schaaf, Santanu Paul, Patricia Mongini, Steven L. Allen, Matthew Kaufman, Kanti Rai, Nicholas Chiorazzi

Blood (2008) 112 (11): 3122.

https://doi.org/10.1182/blood.V112.11.3122.3122

Published: 2008

Journal Articles

p53 and COX-2 Inhibitors Control the Replication and Viability of Non-Transformed and CLL B Lymphocytes

Patricia Mongini, Ph.D., Matthew Kaufman, M.D., Jonathan E. Kolitz, MD, Steven L. Allen, M.D., Joshua Trott, Kanti Rai, M.D., Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 3146.

https://doi.org/10.1182/blood.V112.11.3146.3146

Published: 2008

Journal Articles

Induction of Apoptosis in CLL by Peptides Binding the B-Cell Antigen Receptor in Vitro

Manuela Woelfle, Till Seiler, Rosa Catera, Hartmut Dohner, Stephan Stilgenbauer, MD, PhD, Steven L. Allen, Kanti Rai, Charles Chu, PhD, Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 3151.

https://doi.org/10.1182/blood.V112.11.3151.3151

Published: 2008

Journal Articles

Improved Prognosis of Chronic Lymphocytic Leukemia (CLL) Patients with Increased IgVH Mutations May Reflect Greater Alteration of the B-Cell Receptor (BCR) Binding Site

Matthew Kaufman, MD, Xiao Yan, MD, PhD, Rajendra Damle, PhD, Nina Kohn, MS, Martin Lesser, PhD, Nancy Driscoll, R-PA, Christina Johnson, R-PA, Jahan Aghalar, Yehuda Lebowicz, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 3152.

https://doi.org/10.1182/blood.V112.11.3152.3152

Published: 2008

Journal Articles

A Human Hematopoietic Environment and Autologous T-Cell Growth Support Proliferation of Chronic Lymphocytic Leukemia B Cells in Immune-Deficient Mice

Davide Bagnara, Matthew Kaufman, Xiao J. Yan, MD, PhD, Kanti Rai, Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 26.

https://doi.org/10.1182/blood.V112.11.26.26

Published: 2008

Journal Articles

In Vivo Labeling of Dividing Chronic Lymphocytic Leukemia B Cells Suggests That CXCR4 and CD5 Define the Clonal Subfraction That Recently Proliferatead and Emigrated from a Solid Tissue

Carlo calissano, MD, Rajendra Damle, PhD, Gregory Hayes, PhD, Elisabeth J Murphy, MD, PhD, Marc Hellerstein, MD, PhD, Barbara Sherry, PhD, Matthew S Kaufman, MD, Steven L Allen, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 358.

https://doi.org/10.1182/blood.V112.11.358.358

Published: 2008

Journal Articles

Surprising Lack of Correlation between CD38 and Time to First Treatment in Chronic Lympocytic Leukemia.

Matthew S. Kaufman, MD, Rajendra Damle, PhD, Nina Kohn, MA, Christina Johnson, RPA-C, Nancy Driscoll, RPA-C, Angelica Caramanica, RPA-C, Yehuda Lebowicz, MD, Kai Tsao, MD, Nicholas Chiorazzi, MD, Kanti Rai, MD

Blood (2007) 110 (11): 2058.

https://doi.org/10.1182/blood.V110.11.2058.2058

Published: 2007

Journal Articles

Addition of Oblimersen (Bcl-2 Antisense) to Fludarabine/Cyclophosphamide for Relapsed/Refractory Chronic Lymphocytic Leukemia Extends Survival in Patients Who Achieve CR/nPR: Results from a Randomized Phase 3 Study.

Susan O’Brien, Joseph Moore, Lily Ding, Steven Novick, Kanti Rai

Blood (2007) 110 (11): 751.

https://doi.org/10.1182/blood.V110.11.751.751

Published: 2007

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Foreign antigen delivered to CLL B cells via membrane IgD leads to a distinct antigen processing pathway that allows antigen-specific T cell activation that is superior to membrane IgM delivery

Systematic molecular profiling to identify determinants of response to ibrutinib

Predictors of 90-day mortality in elderly and unfit AML patients treated with single-agent hypomethylating agents or in combination with venetoclax

Normal B Cells in MBL follow divergent maturation pathways that correlate with the IGHV mutation status of the pre-leukemic clone

CLL Stereotyped Subset #4 Igs Acquire Binding to Viable B Lymphocyte Surfaces By Somatic Mutations, Isotype Class Switching, and with the Prerequisite of IG Self-Association

Ibrutinib Disrupts IL-4R - IL-4 Axis By Inhibiting IL-4R Signaling and Reversing Th2/Th1 Polarization through Diminished CLECL1 in CLL B Cells

IgM and IgD Differential CLL BCRs Organization and Interaction with Co-Receptors before and during Ibrutinib Therapy

Reactive Oxygen Species and Metabolic Gene Expression Profiling Further Differentiate CXCR4/CD5 Fractions in Chronic Lymphocytic Leukemia

Myeloid-Derived Suppressor Cell Subtypes Are Responsible for the Th2 Phenotype of T Cells in CLL

B Cells of the Proliferative Fraction of CLL Clones Exhibit Activated B-Cell and Myeloid-Cell Signatures Suggesting Enhanced Antigen-Presentation, Integrin Responsiveness, and IL-4 Receptiveness: Additional Targets for CLL Therapy

Fcgammariib Expression As a Prognostic Marker in Chronic Lymphocytic Leukemia

The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia

Efficiency of BCR: Anti-BCR Interaction Dictates Cellular Outcomes of Signaling in Chronic Lymphocytic Leukemia Cells

p53 and COX-2 Inhibitors Control the Replication and Viability of Non-Transformed and CLL B Lymphocytes

Induction of Apoptosis in CLL by Peptides Binding the B-Cell Antigen Receptor in Vitro

Improved Prognosis of Chronic Lymphocytic Leukemia (CLL) Patients with Increased IgVH Mutations May Reflect Greater Alteration of the B-Cell Receptor (BCR) Binding Site

A Human Hematopoietic Environment and Autologous T-Cell Growth Support Proliferation of Chronic Lymphocytic Leukemia B Cells in Immune-Deficient Mice

In Vivo Labeling of Dividing Chronic Lymphocytic Leukemia B Cells Suggests That CXCR4 and CD5 Define the Clonal Subfraction That Recently Proliferatead and Emigrated from a Solid Tissue

Surprising Lack of Correlation between CD38 and Time to First Treatment in Chronic Lympocytic Leukemia.

Addition of Oblimersen (Bcl-2 Antisense) to Fludarabine/Cyclophosphamide for Relapsed/Refractory Chronic Lymphocytic Leukemia Extends Survival in Patients Who Achieve CR/nPR: Results from a Randomized Phase 3 Study.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only